William F. Fearon, MD

Original Contribution

Feasibility and Safety of the Second-Generation, Frequency Domain Optical Coherence Tomography (FD-OCT): A Multicenter Study

04/26/2012

Marco A. Costa , MD, PhD;

Luca Di Vito , MD, PhD;

Joo Heung Yoon , MD;

Shaosong Zhang , MD, PhD;

William F. Fearon , MD;

Ik-Kyung Jang , MD, PhD;

Jeffrey W. Moses , MD;

Alan C. Yeung , MD;

Hiram G. Bezerra , MD, PhD;

Abstract: Objectives. This study sought to assess the effectiveness and safety of the second-generation frequency-domain optical coherence tomography (FD-OCT) system. Background. The second-generation FD-OCT was recently developed, with...

Abstract: Objectives. This study...

04/26/2012

Journal of Invasive Cardiology

Clinical Editor's Corner

Your Patient Took Sildenafil Last Night. Should You Cancel the Cardiac Catheterization This Morning?

12/06/2020

Lloyd W. Klein , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Michael Ragosta , MD;

David J. Cohen , MD, MPH, MSc;

J. Dawn Abbott , MD;

Samuel M. Butman , MD;

William F. Fearon , MD;

Listen in to Dr. Kern and Dr. Lloyd Klein as they discuss this article in a 30-minute Clinical Editor's Corner Live presentation.

Listen in to Dr. Kern and Dr....

12/06/2020

Cath Lab Digest

Figure 1. “New Dog” (see Table): Cath lab team without lead aprons behind the Protego system (Image Diagnostics).

Clinical Editor's Corner

Optimal Angiography Post PCI: Should the Guidewire Stay In or Out? Do Small Changes in Cath Lab Techniques Matter?

01/04/2024

Morton J. Kern , MD, MSCAI, FACC, FAHA;

William F. Fearon , MD;

Matheen A. Khuddus ;

Arnold H. Seto , MD, MPA, CCDS, FACC, FSCAI;

James C. Blankenship , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Dr. Kern and his expert colleagues discuss a specific angiographic question: “Should final angiography always be done with the guide wire in or out of the artery?”

Dr. Kern and his expert...

01/04/2024

Cath Lab Digest

Clinical Editor's Corner

TAVR: Who Should Prep the Device? The Role of Industry Representatives’ Participation in the Cath Lab

01/03/2022

Christopher J. White , DO, MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Michael Ragosta , MD;

David J. Cohen , MD, MPH, MSc;

Ramon Quesada , MD, FACP, FACC, FSCAI;

Susheel K. Kodali , MD;

Stephen R. Ramee , MD;

Samuel M. Butman , MD;

Amir Kaki , MD, FACC, FSCAI;

Duane S. Pinto , MD, MPH;

William F. Fearon , MD;

Mauricio G. Cohen , MD, FACC;

Robert J. Applegate , MD;

Aaron V. Kaplan ;

David G. Rizik , MD, FACC, FSCAI;

Jeffrey Marshall ;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

After years of having the industry clinical support staff prep the transcatheter aortic valve replacement (TAVR) valves in the lab (without a single adverse event because of faulty prep, to my knowledge) some administrators have now begun to...

After years of having the...

01/03/2022

Cath Lab Digest

Trial to Lab

The FAME Trial: Measuring FFR Leads to Better Outcomes and Fewer Stents

09/14/2009

William F. Fearon , MD;

Could FAME lead the way for PCI to show superiority over medical therapy and CABG for multivessel coronary artery disease? What were the results of the FAME (Fractional Flow Reserve versus Angiography for Guiding PCI in Patients with...

Could FAME lead the way for PCI...

09/14/2009

Cath Lab Digest

FAME II: High-Risk, Stable CAD Patients Randomized to FFR-Guided PCI with OMT vs. OMT Alone

03/02/2012

William F. Fearon , MD;

An interim analysis of the FAME II trial found a highly statistically significant reduction in the need for hospital readmission and urgent revascularization when fractional flow reserve (FFR) was used to direct treatment. As a result, the...

An interim analysis of the FAME...

03/02/2012

Cath Lab Digest